Published in Drug Metab Dispos on August 01, 2004
Co-administration of grapefruit juice increases bioavailability of tacrolimus in liver transplant patients: a prospective study. Eur J Clin Pharmacol (2009) 0.95
Tacrolimus severe overdosage after intake of masked grapefruit in orange marmalade. Eur J Clin Pharmacol (2007) 0.84
Cranberry juice suppressed the diclofenac metabolism by human liver microsomes, but not in healthy human subjects. Br J Clin Pharmacol (2009) 0.84
The effects of pummelo juice on pharmacokinetics of sildenafil in healthy adult male Jordanian volunteers. Eur J Clin Pharmacol (2009) 0.80
Different influences on tacrolimus pharmacokinetics by coadministrations of zhi ke and zhi shi in rats. Evid Based Complement Alternat Med (2011) 0.77
Suspected Interaction of Cranberry Juice Extracts and Tacrolimus Serum Levels: A Case Report. Cureus (2016) 0.75
Brain pericytes contribute to the induction and up-regulation of blood-brain barrier functions through transforming growth factor-beta production. Brain Res (2005) 1.76
Digoxin up-regulates multidrug resistance transporter (MDR1) mRNA and simultaneously down-regulates steroid xenobiotic receptor mRNA. Biochem Biophys Res Commun (2003) 1.48
Receptor occupancy-based analysis of the contributions of various receptors to antipsychotics-induced weight gain and diabetes mellitus. Drug Metab Pharmacokinet (2005) 1.32
Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein. Clin Pharmacol Ther (2002) 1.28
Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B. Drug Metab Dispos (2005) 1.19
Co-administration of proton pump inhibitors delays elimination of plasma methotrexate in high-dose methotrexate therapy. Br J Clin Pharmacol (2008) 1.08
H(+)-linked transport of salicylic acid, an NSAID, in the human trophoblast cell line BeWo. Am J Physiol Cell Physiol (2002) 1.06
Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux. Br J Pharmacol (2004) 1.06
Receptor occupancy theory-based analysis of antiemetic effects and standard doses of 5-HT3 receptor antagonists in cancer patients. Cancer Chemother Pharmacol (2004) 1.01
Transforming growth factor-beta1 upregulates the tight junction and P-glycoprotein of brain microvascular endothelial cells. Cell Mol Neurobiol (2004) 1.00
Kinetic analysis of P-glycoprotein-mediated transport by using normal human placental brush-border membrane vesicles. Pharm Res (2003) 0.97
Effects of uremic serum and uremic toxins on hepatic uptake of digoxin. Ther Drug Monit (2008) 0.96
Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines. Cancer Chemother Pharmacol (2007) 0.93
Effects of herbal extracts on the function of human organic anion-transporting polypeptide OATP-B. Drug Metab Dispos (2006) 0.93
Functional analysis of organic cation transporter 3 expressed in human placenta. J Pharmacol Exp Ther (2005) 0.93
Pharmacokinetic-pharmacodynamic analysis of antipsychotics-induced extrapyramidal symptoms based on receptor occupancy theory incorporating endogenous dopamine release. Drug Metab Pharmacokinet (2005) 0.92
Uptake and efflux of quinacrine, a candidate for the treatment of prion diseases, at the blood-brain barrier. Cell Mol Neurobiol (2004) 0.91
Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line. Drug Metab Dispos (2005) 0.89
Inhibitory effects of herbal extracts on the activity of human sulfotransferase isoform sulfotransferase 1A3 (SULT1A3). Biol Pharm Bull (2009) 0.88
Genetic polymorphisms in the 5-hydroxytryptamine type 3B receptor gene and paroxetine-induced nausea. Int J Neuropsychopharmacol (2007) 0.86
Effects of dosing interval on the pharmacokinetic interaction between oral small spherical activated charcoal and amlodipine in humans. J Clin Pharmacol (2007) 0.85
Effects of grapefruit juice and orange juice on the intestinal efflux of P-glycoprotein substrates. Pharm Res (2002) 0.85
Polymorphisms and linkage disequilibrium of the OATP8 (OATP1B3) gene in Japanese subjects. Drug Metab Pharmacokinet (2006) 0.84
Prediction and evaluation of fetal toxicity induced by NSAIDs using transplacental kinetic parameters obtained from human placental perfusion studies. Br J Clin Pharmacol (2012) 0.84
Community pharmacists' attitudes relating to patients' use of health products in Japan. Int J Clin Pharm (2012) 0.84
Functional characterization of human monocarboxylate transporter 6 (SLC16A5). Drug Metab Dispos (2005) 0.82
Inhibitory effects of herbal extracts on breast cancer resistance protein (BCRP) and structure-inhibitory potency relationship of isoflavonoids. Drug Metab Pharmacokinet (2010) 0.82
Potentiation of domperidone-induced catalepsy by a P-glycoprotein inhibitor, cyclosporin A. Biopharm Drug Dispos (2003) 0.82
Transport and uptake of nateglinide in Caco-2 cells and its inhibitory effect on human monocarboxylate transporter MCT1. Br J Pharmacol (2002) 0.82
Increased anticoagulant activity of warfarin used in combination with doxifluridine. Cancer Chemother Pharmacol (2010) 0.81
Inhibitory effects of various beverages on human recombinant sulfotransferase isoforms SULT1A1 and SULT1A3. Biopharm Drug Dispos (2007) 0.81
Up-regulation of MDR1 function and expression by cisplatin in LLC-PK1 cells. Biol Pharm Bull (2003) 0.81
Influence of SLCO1B3 gene polymorphism on the pharmacokinetics of digoxin in terminal renal failure. Drug Metab Pharmacokinet (2008) 0.80
Inhibitory effects of various beverages on ritodrine sulfation by recombinant human sulfotransferase isoforms SULT1A1 and SULT1A3. Pharm Res (2005) 0.80
The first case of phenytoin intoxication associated with the concomitant use of phenytoin and TS-1, a combination preparation of tegafur, gimeracil, and oteracil potassium. Cancer Chemother Pharmacol (2007) 0.80
Kinetic analysis of the transport of salicylic acid, a nonsteroidal anti-inflammatory drug, across human placenta. Drug Metab Dispos (2007) 0.80
Effect of aromatase inhibitors on bone mineral density in a Japanese breast cancer population. Drug Metab Pharmacokinet (2013) 0.80
Understanding of definition and safety of oral health products among patients, physicians and pharmacists. Yakugaku Zasshi (2010) 0.79
Transluminal gene transfer into brain capillary endothelial cells in vivo with HVJ-liposomes. J Drug Target (2002) 0.79
Inhibitory effects of angiotensin II receptor antagonists and leukotriene receptor antagonists on the transport of human organic anion transporter 4. J Pharm Pharmacol (2006) 0.79
Digoxin up-regulates MDR1 in human colon carcinoma Caco-2 cells. Biochem Biophys Res Commun (2002) 0.79
Pharmacokinetic modelling of the interaction between St John's wort and ciclosporin A. Br J Clin Pharmacol (2006) 0.79
Effect of smoking and CYP2D6 polymorphisms on the extent of fluvoxamine-alprazolam interaction in patients with psychosomatic disease. Eur J Clin Pharmacol (2009) 0.79
Comparison of the inhibitory profiles of itraconazole and cimetidine in cytochrome P450 3A4 genetic variants. Drug Metab Dispos (2011) 0.79
In vivo delivery of glial cell-derived neurotrophic factor across the blood-brain barrier by gene transfer into brain capillary endothelial cells. Hum Gene Ther (2003) 0.79